Q5140 Injection adalimumab-fkjp, 1 milligrams
Also known as: Adalimumab-fkjp injection, TNF-alpha inhibitor
Injection of adalimumab-fkjp biosimilar per 1 milligram, a tumor necrosis factor alpha inhibitor.
In Plain Language
anti-inflammatory biologic; immune suppressor
Clinical Context
Used for rheumatoid arthritis, psoriasis, Crohn's disease, and other autoimmune inflammatory conditions.
RVU Information
CPT Q5140 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5140?
CPT Q5140 (Injection adalimumab-fkjp, 1 milligrams) is a Q Codes code. Injection of adalimumab-fkjp biosimilar per 1 milligram, a tumor necrosis factor alpha inhibitor.
Is Q5140 covered by insurance?
Q5140 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for rheumatoid arthritis, psoriasis, Crohn's disease, and other autoimmune inflammatory conditions.
When is CPT Q5140 used?
Used for rheumatoid arthritis, psoriasis, Crohn's disease, and other autoimmune inflammatory conditions.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.